On Friday, Opko Health Inc (NASDAQ: OPK) opened higher 0.53% from the last session, before settling in for the closing price of $1.89. Price fluctuations for OPK have ranged from $0.86 to $2.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 1.59% over the past five years. Company’s average yearly earnings per share was noted -287.50% at the time writing. With a float of $303.61 million, this company’s outstanding shares have now reached $671.55 million.
Let’s look at the performance matrix of the company that is accounted for 2997 employees. In terms of profitability, gross margin is 24.77%, operating margin of -21.32%, and the pretax margin is -1.45%.
Opko Health Inc (OPK) Insider Updates
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Opko Health Inc is 54.79%, while institutional ownership is 31.40%. The most recent insider transaction that took place on Feb 28 ’25, was worth 115,312. In this transaction CEO & Chairman of this company bought 67,434 shares at a rate of $1.71, taking the stock ownership to the 213,301,448 shares. Before that another transaction happened on Jan 28 ’25, when Company’s CEO & Chairman bought 47,537 for $1.47, making the entire transaction worth $70,060. This insider now owns 213,234,014 shares in total.
Opko Health Inc (OPK) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -287.50% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.20% during the next five years compared to 32.04% growth over the previous five years of trading.
Opko Health Inc (NASDAQ: OPK) Trading Performance Indicators
Check out the current performance indicators for Opko Health Inc (OPK). In the past quarter, the stock posted a quick ratio of 3.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.09, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.25 in one year’s time.
Technical Analysis of Opko Health Inc (OPK)
Opko Health Inc (NASDAQ: OPK) saw its 5-day average volume 21.25 million, a positive change from its year-to-date volume of 5.27 million. As of the previous 9 days, the stock’s Stochastic %D was 69.88%. Additionally, its Average True Range was 0.09.
During the past 100 days, Opko Health Inc’s (OPK) raw stochastic average was set at 79.70%, which indicates a significant increase from 67.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.10% in the past 14 days, which was higher than the 38.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5868, while its 200-day Moving Average is $1.4998. Nevertheless, the first resistance level for the watch stands at $1.9417 in the near term. At $1.9833, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0267. If the price goes on to break the first support level at $1.8567, it is likely to go to the next support level at $1.8133. Assuming the price breaks the second support level, the third support level stands at $1.7717.
Opko Health Inc (NASDAQ: OPK) Key Stats
There are currently 671,550K shares outstanding in the company with a market cap of 1.28 billion. Presently, the company’s annual sales total 713,100 K according to its annual income of -53,200 K. Last quarter, the company’s sales amounted to 183,600 K and its income totaled 14,000 K.
